Strategic healthcare M&A rebounded in 2021 from a down year in pandemic-ravaged 2020, with volume up 16% and total deal value rising by 44%, to $440 billion, Bain & Company reports. The year 2021 brought with it a return to pre-pandemic trends across all five sectors: pharmaceuticals, medtech, payers, providers, and healthcare services. What’s different this time, though, is that the cost of acquisitions has become dramatically more expensive in most areas, with deal multiples reaching the highest level in decades. Paying for these inflated multiples requires companies to get more creative in their deal theses and focus on better execution to deliver on deal value. Here’s what the best acquirers are doing. Read more.
‘Get That Money!’ Dermatologist Says Patient Care Suffered After Private Equity-Backed Firm Bought Her Practice
Dr. Allison Brown, a board-certified dermatologist and dermatopathologist says Pinnacle terminated her shortly after she advised management of questionable practices.
December 23, 2021
All the various forms of concierge medicine represent a return to privatizing primary health care.
October 17, 2022
The paper, published in the Annals of Internal Medicine, cautions that the existing healthcare system resembles a "medical-industrial complex."
September 8, 2021